Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Undiagnosed Diseases 1Pulmonary Disease, Chronic Obstructive 1Medication Adherence 1

Interventions

pembrolizumab 439Carboplatin 322Nivolumab 298Cyclophosphamide 286Specimen Handling 271Magnetic Resonance Spectroscopy 259Cisplatin 250Paclitaxel 249Radiotherapy 230Dexamethasone 184Biopsy 182Gemcitabine 180durvalumab 171atezolizumab 152Doxorubicin 141Rituximab 138Lenalidomide 136Ipilimumab 134Docetaxel 132Bevacizumab 132Radiation 121Capecitabine 120Oxaliplatin 116Etoposide 116Radiosurgery 113Fluorouracil 112Pemetrexed 109fludarabine 106venetoclax 102Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × General Practitioners × Clear all
NCT05444062 2025-08-11

QLC+

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase NA Active not recruiting
330 enrolled

Undiagnosed Diseases, Pulmonary Disease, Chronic Obstructive, Medication Adherence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡